Browsing by Author Olgun, N.

Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
2016Assessment of Clinical Importance of Molecular Basis of Neuroblastoma: Can High Risk Group Be Categorized as High Risk and Ultra-High Risk?Demir, B.; Aktas, S.; Altun, Z.; Ercetin, P.; Olgun, N.
2018Could Manganese-Superoxide Dismutase Be a Biomarker in Neuroblastoma?Altun, Z.; Aktas, S.; Demir, B.; Serinan, E.; Aktas, T.; Olgun, N.
2021Questioning How To Define the Ultra-High Subgroup of Neuroblastoma PatientsDemir, A. B. ; Aktas, S.; Altun, Z.; Ercetin, P.; Aktas, T. C.; Olgun, N.